ClinicalTrials.gg
CompletedNCT06179901Updated Mar 19, 2025

The Effect of Early MSAT Treatment on Sciatica Caused by Traffic Accidents.

An interventional study of Integrative Korean Medicine Treatment and lower limb motion style acupuncture treatment in Sciatica, Radiating Pain and Paresthesia, sponsored by Jaseng Medical Foundation. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years to 69 Years. Per ClinicalTrials.gov, last updated 2025-03-19.

Sponsored by Jaseng Medical Foundation · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
19 Years to 69 Years
Sex
All
01

Study summary

The investigators would like to conduct a pilot study prior to a practical randomized control study on the effectiveness of initial MSAT treatment on inpatients complaining of radiating pain and abnormal sensation in the lower extremities caused by traffic accidents.

Read the detailed description

The stimulation of the nerve roots due to physicochemical causes can lead to symptoms along the distribution area of those nerves, such as radiating pain, numbness, a sensation of heat, dullness in sensation, muscle weakness, and more. While radiating pain and abnormal sensations typically arise from lumbar disc herniation, they can also result from peripheral nerve entrapment, like in radiculopathy. Traditional Korean medicine treatments for radiating pain involve acupuncture, pharmacoacupuncture, moxibustion, cupping and Chuna therapy.

Motion Style Acupuncture Treatment (MSAT) combines traditional acupuncture with neurophysiological theories, focusing on administering acupuncture at the affected area and subsequently involving active or passive movements. Studies have shown the efficacy of MSAT in treating various acute and chronic neuromuscular disorders like low back pain, brachial plexus injury, and temporomandibular joint disorders. Although there have been reports of the effectiveness of pelvic MSAT treatment in patients complaining of lumbar and radiating pain due to lumbar disc herniation, research on the initial effects of MSAT treatment specifically targeting traffic accident victims is still lacking. MSAT has been developed as an emergency acupuncture method that enhances blood circulation by adding movement to traditional acupuncture, offering quick pain relief and restoring range of motion.

Given the significant impact of a traffic accident, positive effects could be anticipated in alleviating radiating pain and restoring reduced range of motion through MSAT, especially when these symptoms arise following such a traumatic event.

02

Conditions studied

  • Sciatica
  • Radiating Pain
  • Paresthesia
  • Dysesthesia

Keywords

  • MSAT
  • Sciatica
  • Radiating pain
  • Paresthesia
  • Dysesthesia
  • Acupuncture
03

In context

Sciatica

149 studies on the registry are indexed under Sciatica; 31 are open to participants now.

This study's enrollment of 40 is below the median of 68 across 122 interventional studies indexed under Sciatica.

Browse Sciatica studies →

Lead sponsor

Jaseng Medical Foundation is the lead sponsor of 69 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. a person who has no problem in language communication
  2. men and women between the ages of 19 and 69
  3. a patient hospitalized for treatment in a car accident
  4. A person who complains of radiating pain or abnormal sensation in the lower extremities within three days after a traffic accident
  5. A person with a lower extremity radiating pain or abnormal sensation of NRS (Numeric Rating Scale) 5 or higher
  6. A person who voluntarily agrees to participate in clinical trials and signs a consent form

Exclusion criteria

Exclusion Criteria:

  1. Patient diagnosed with certain serious diseases that may cause radiation pain: malignant tumors, spinal fractures, spinal infections, inflammatory spondylitis, etc
  2. Patient with progressive neurological deficits or severe neurological symptoms such as Mami syndrome
  3. Patient who has undergone surgery, procedures, or is scheduled to undergo surgery on the lumbar spine or lower extremities within the last 3 weeks
  4. Patient with other chronic conditions that may interfere with interpretation of treatment effects or results: cardiovascular disease, kidney disease, active hepatitis, diabetic neuropathy, dementia, severe mental illness, epilepsy, etc
  5. Patient who may be inadequate or unsafe with acupuncture treatment: hemorrhagic disease, people on anticoagulant therapy, people with severe cardiovascular disease, pregnancy, and infection Severe diabetic patients, seizure disorders, etc. that are concerned
  6. Patient currently taking , , mental illness medications or other medications that may affect research results
  7. Patient Participating in clinical trials other than observational studies without therapeutic intervention
  8. Patient who has difficulty filling out consent forms to participate in research
  9. Patient deemed difficult to conduct this clinical study when judged by the research director
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    Integrative Korean Medicine Treatment group(IKMT group)

    Procedure: Integrative Korean Medicine Treatment

  • Experimental
    MSAT group

    Procedure: Integrative Korean Medicine Treatment · Procedure: lower limb motion style acupuncture treatment

Interventions

  • ProcedureIntegrative Korean Medicine Treatment

    acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine, cupping, moxibustion.

  • Procedurelower limb motion style acupuncture treatment

    Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation.

06

What researchers measure

Primary outcomes

  1. Numeric Rating Scale of sciatica(NRS of sciatica)

    The degree of radiation pain or abnormal sensation in the patient is evaluated through a numerical pain scale. The numerical pain scale is an index expressed by objectifying the degree of subjective pain into numbers for patients over 12 years of age who can communicate and understand the concept of numbers. The patient's pain level is quantified by zero pain and ten pain that cannot be tolerated as death, and is mild (1-4 points), moderate (5-6 points), and severe (7-10 points).

    Time frame: visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission)

Secondary outcomes

  1. NRS of Lower back pain(NRS of LBP)

    In addition to radiation pain and abnormal sensation, the degree of additional low back pain is evaluated together on a numerical pain scale. Write the degree of pain of the patient by stating that the state without pain at all is 0, and the pain that cannot be tolerated as if dying is 10.

    Time frame: visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission)

  2. Oswestry disability index(ODI)

    It is a questionnaire that measures the discomfort patients feel in their daily lives due to back pain, radiating pain in the lower extremities, and abnormal sensations. It is a functional evaluation tool that measures the availability of 10 daily activity.

    Time frame: visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission)

  3. European Quality of Life-5 Dimensions(EQ-5D)

    EQ-5D is one of the most widely used tools in the health care sector to measure health-related quality of life (HRQOL). It is a questionnaire that evaluates the current HRQOL by dividing it into five categories: mobility (M), self-care (SC), user activity (UA), pain/disability (PD), and anxiety/depression (AD). Each item is evaluated in Phase 1 (no problem at all), Phase 2 (slight problem), Phase 3 (moderate problem), Phase 4 (severe problem), and Phase 5 (severe problem). The EQ-5D Index is an index that calculates health status as a quantitative single value by assigning quality weights to each of the five items of EQ-5D. In this study, quality weights for Koreans at the Korea Centers for Disease Control and Prevention are used and calculated as in the formula below. EQ-5D Index = = 1 - (0.05 + 0.096 × M2 + 0.418 × M3 + 0.046 × SC2 + 0.136 × SC3 + 0.051 × UA2 + 0.208 × UA3 + 0.037 × PD2 + 0.151 × PD3 + 0.043 × AD2 + 0.158 × AD3 + 0.050 × N3)

    Time frame: visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission)

  4. Patient Global Impression of Change(PGIC)

    PGIC is an index that subjectively evaluates the degree of improvement after treatment by patients. The subjective criteria for improvement and deterioration are ambiguous, so it is usually used as a tool to evaluate treatment satisfaction. The criteria can be checked by analyzing changes in pain and dysfunction indicators for patients who are satisfied with treatment.

    Time frame: visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission)

  5. Straight Leg Raise Test(SLRT)

    It is a physical test performed on patients complaining of urticaria and radial pain and is performed in an supine position. The examiner holds the patient's heel with one hand, holds the patient's knee with the other hand, and raises his leg to bend the hip joint while fixing it so that the patient's knee does not bend. Check the angle at which the patient feels uncomfortable with back pain or radiating pain. If the knee muscle is a problem when the lower extremity is upright, it is simply related to the back of the thigh, and if the lower extremity radiating pain appears along with nerve driving, it is considered positive. If there is a space-occupying disease such as intervertebral disc hernia, it may indicate back pain or radial pain on the affected side during the tendon examination. Since it is a method of reproducing the patient's pain, the tendon leg is performed first and then the affected leg is examined.

    Time frame: visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission)

  6. Lumbar Range of motion(Lumbar ROM)

    Measure the active range of lumbar flexion, extension, lateral flexion, and rotation. Evaluate whether there is a limitation in the range of motion due to the patient's back pain and radiating pain.

    Time frame: visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission)

  7. Adverse event(AE)

    It refers to undesirable and unintended objective symptoms, subjective symptoms, or diseases that appear after the procedure during the clinical trial process. It is not necessary to have a causal relationship with the procedure. During the study period, it is collected through patient symptom reports and researcher observations, and the causal relationship between the types of adverse reactions and treatment interventions is written on the EMR. Follow-up observation is conducted when an adverse reaction occurs, and if a serious level of adverse reaction is found, report it quickly.

    Time frame: visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission)

  8. Severity of L-spine HIVD(Herniated intervertebral disc) or lumbar stenosis on MRI

    Data is collected retrospectively through EMR records for research patients who took L-SPINE MRI. The degree of escape and stenosis of the intervertebral disc on MRI is divided into mild, subtle, moderate, and severe. The stage of intervertebral disc escape is divided into bulding, protusion, extrusion, and sequencing, and the direction of escape is classified into central, subarticular, formal, lateral, and interior. Stenosis will be classified as central, lateral repair, and formal. L-spine MRI is evaluated through retrospective chart review during the study period regardless of the patient's admission and discharge.

    Time frame: through study completion, an average of 1 month

07

Study locations

1 site
  • Jaseng Hospital of Korean Medicine
    Seoul, Gangnam-Gu 135-896, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06179901
Lead sponsor
Jaseng Medical Foundation
Responsible party
In-Hyuk Ha, KMD (Director, Jaseng Medical Foundation) — Principal investigator
First posted
Dec 22, 2023
Start date
Oct 30, 2023
Primary completion
Oct 6, 2024
Completion
Oct 15, 2024
Last update
Mar 19, 2025

Study contacts

In-Hyuk Ha, PhD
study chair · Bucheon Jaseng Hospital of Korean Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion